Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Sometimes patients need specific dosages, formulations, or preparations that are not commercially available
What follows is a thorough, unbiased look at Pomegranate Health, covering the details that actually matter when you are investing in your health
1 Long-term evidence from SURPASS-4 The SURPASS-4 trial followed participants for up to 104 weeks (2 years), providing reassurance about longer-term use
Their virtual patients were randomly assigned to control or various GLP-1 RA exposures: Semaglutide Tirzepatide Liraglutide Dulaglutide
Eli Lilly just delivered one of the biggest obesity-drug headlines of 2026
US$ 21.40
US$ 29.90
US$ 28.17
US$ 26.05
US$ 22.79
US$ 23.36
US$ 27.24
